{'fraction_non_alphanumeric': 0.017142857142857144, 'fraction_numerical': 0.0, 'mean_word_length': 5.5514018691588785, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The use of immune drugs for the treatment of patients with acute staphylococcal pneumonia

In patients with acute staphylococcal pneumonia, which occurred against the background of chronic obstructive bronchitis, pronounced changes in the immunological reactivity of the body were revealed, manifested by a decrease in the ability of T-lymphocytes to blast transformation, inhibition and deregulation of the interaction of T- and B-immune systems, a decrease in nonspecific protection factors. The effectiveness of the use of targeted immune drugs and retabolil in the complex treatment of patients has been established. In addition, their use reduces the possibility of sluggish lingering pneumonia.